Epigallocatechin 3-gallate (EGCG) inhibits ERK and activates JNK, thus fostering apoptotic cell death by the release of cytochrome c in human colon cancer cells (Cerezo-Guisado et al., 2015). This evidence concerns the gene MAPK8 and malignant colon neoplasm.